Androgenetic Alopecia Tied to Impaired HRQoL
The link between androgenetic alopecia (AGA) and health-related quality of life (HRQOL) and psychiatric disorders was examined.
General Dermatology
Intense Pulsed Light Treatment Improves Dry Eye Disease Symptoms
Patients demonstrated improvements in tear film lipid layer, non-invasive tear breakup time, and meibum gland characteristics.
Combination Antiretroviral Therapy and CD4/CD8 Ratio on the Risk for Kaposi Sarcoma, Non-Hodgkin Lymphoma in Patients With HIV Infection
Researchers sough to assess the relationship between CD4/CD8 ratios and the risk for Kaposi sarcoma and non-Hodgkin lymphoma among patients with HIV infection treated with combination antiretroviral therapy.
Lidocaine HCI Topical Solution Recalled Due to Super Potency
The recalled lot of Lidocaine HCl Topical Solution 4% (40mg/mL) was distributed at the wholesale and retail distribution levels.
Characterizing Patient-Reported Skin Reactions to 5-Fluorouracil in Actinic Keratosis
The frequency and severity of skin reactions in patients with actinic keratosis is evaluated.
Long-Term Benefit of Topical Therapies for Actinic Keratosis Unstudied
The efficacy of commonly prescribed topicals for the treatment of actinic keratosis is reviewed.
Rilzabrutinib Fails in Phase 3 Pemphigus Trial
Rilzabrutinib is an oral Bruton tyrosine kinase inhibitor currently in development for a number of immune-mediated diseases.
NMA Shows Long-Term Efficacy of Treatments for Actinic Keratosis
The long-term of interventions for actinic keratosis from parallel-arm randomized clinical trials are assessed.
Hidradenitis Suppurativa Care Utilization in Adults vs Children
The clinical characteristics and healthcare utilization patterns of pediatric vs adult patients with HS were investigated.
Topical for Seborrheic Keratoses May Be Effective Alternative to Surgical Procedures
The efficacy and tolerability of a topical agent in the treatment of seborrheic keratosis is evaluated.
- Loading...
Loading...
Next post in General Dermatology
Loading... 
Loading...